Scholarlink

<p>Smaller quasi-experimental studies and short-term controlled trials of medically tailored meals (MTMs) have shown health benefits for several conditions, but MTMs have not been evaluated in large-scale policy initiatives. Multiple US states are now implementing MTMs in Medicaid, the health insurance program for low-income individuals, yet their impact has not been evaluated. We investigated changes in hospitalizations, emergency department (ED) visits and healthcare costs among 1,866 MTM recipients and 1,372 comparators from 2020 to 2023 across 11 health systems in Massachusetts. Both groups met eligibility criteria for diet-related conditions and food insecurity. We used propensity overlap-weighted generalized estimating equations to compare a 6-month baseline period to the program period. MTM receipt (mean, 6.7 months) was associated with 31% fewer hospitalizations (adjusted incidence rate ratio (aIRR) = 0.69 (95% confidence interval (CI): 0.58−0.82)), 20% fewer ED visits (aIRR = 0.80 (95% CI: 0.72−0.89)) and US$3,433 lower total healthcare costs (95% CI: $−1,215 to −$5,651). Healthcare cost reductions offset 98% of the MTM program costs during the enrollment period. Findings were robust across sensitivity analyses, a negative control test and a secondary comparison group. In stratified analyses, MTM receipt was net cost-saving among participants with cardiovascular disease, chronic kidney disease, depression, diabetes or high comorbidity. This large MTM policy evaluation informs consideration of ‘food is medicine’ therapies in clinical care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Medically tailored meals receipt and healthcare utilization and costs in Massachusetts’ Medicaid demonstration

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月2日

查看全文
  • Kurt Hager,
  • Matthew Alcusky,
  • Fang Fang Zhang,
  • Gary Sing,
  • Arlene Ash,
  • Eric Mick,
  • Jean Terranova,
  • Erin DiBacco,
  • Stephanie Buckler,
  • Allison Rich,
  • Jessica Bowman,
  • Sara Folta,
  • Kim Prendergast,
  • Jasper Frank,
  • Cheryl Ball,
  • Jenny S. Chiang,
  • Dariush Mozaffarian

摘要

Smaller quasi-experimental studies and short-term controlled trials of medically tailored meals (MTMs) have shown health benefits for several conditions, but MTMs have not been evaluated in large-scale policy initiatives. Multiple US states are now implementing MTMs in Medicaid, the health insurance program for low-income individuals, yet their impact has not been evaluated. We investigated changes in hospitalizations, emergency department (ED) visits and healthcare costs among 1,866 MTM recipients and 1,372 comparators from 2020 to 2023 across 11 health systems in Massachusetts. Both groups met eligibility criteria for diet-related conditions and food insecurity. We used propensity overlap-weighted generalized estimating equations to compare a 6-month baseline period to the program period. MTM receipt (mean, 6.7 months) was associated with 31% fewer hospitalizations (adjusted incidence rate ratio (aIRR) = 0.69 (95% confidence interval (CI): 0.58−0.82)), 20% fewer ED visits (aIRR = 0.80 (95% CI: 0.72−0.89)) and US$3,433 lower total healthcare costs (95% CI: $−1,215 to −$5,651). Healthcare cost reductions offset 98% of the MTM program costs during the enrollment period. Findings were robust across sensitivity analyses, a negative control test and a secondary comparison group. In stratified analyses, MTM receipt was net cost-saving among participants with cardiovascular disease, chronic kidney disease, depression, diabetes or high comorbidity. This large MTM policy evaluation informs consideration of ‘food is medicine’ therapies in clinical care.